Overview

Support to European and Developing Countries Clinical Trials Partnership to accelerate development of new or improved druugs , vaccines, microbicides and diagnostics against HIV/AIDS; TB and malaria. Support provided since 2004. A new expanded programme is planned within Horizon2020 which will be called EDCTP2.

Involved parties

:
-
:
EDCTP/European & Developing Countries Clinical Trials Partnership
:
EDCTP/European & Developing Countries Clinical Trials Partnership
:
  • B03 - Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO)

Strategies governing the contribution

  1. Research cooperation 2015-2022184,975,000 SEK 100% of total

Geographical allocation of the contribution

No countries have been assigned to this contribution.

Development areas for the contribution

No development areas have been assigned to this contribution.

Duration of the contribution

December 1, 2015
December 31, 2027
Ongoing

Committed and disbursed amount

Agreed amount SEK 184,975,000

Paid amount SEK 184,975,000

Paid per year (net value)

  • 2015: SEK 25,000,000
  • 2016: SEK 37,500,000
  • 2017: SEK 37,500,000
  • 2019: SEK 25,000,000
  • 2020: SEK 32,300,000
  • 2021: SEK 27,675,000

Sustainable Development Goals

The contributions contribution to the UN's global sustainability goals.

  • Global Goals, goal 3: Good health and well-being